However, it is not known if BCG, like LPS (Figures 4, 5), activates MyD88 to stabilize IAP proteins in bladder cancer cells and if the subsequent increase of IAP proteins contributes to the failure of BCG in treating some cases of bladder cancer. Here, MYD88 is linked to urinary bladder carcinoma.